<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>zoonotic diseases &#8211; Science</title>
	<atom:link href="https://scienmag.com/tag/zoonotic-diseases/feed/" rel="self" type="application/rss+xml" />
	<link>https://scienmag.com</link>
	<description></description>
	<lastBuildDate>Fri, 02 Oct 2026 09:33:44 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://scienmag.com/wp-content/uploads/2024/07/cropped-scienmag_ico-32x32.jpg</url>
	<title>zoonotic diseases &#8211; Science</title>
	<link>https://scienmag.com</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">73899611</site>	<item>
		<title>Pirbright Study Links COVID-19 Immunity to Bat Coronavirus Protection</title>
		<link>https://scienmag.com/pirbright-study-links-covid-19-immunity-to-bat-coronavirus-protection/</link>
		
		<dc:creator><![CDATA[Kristina Jarvis]]></dc:creator>
		<pubDate>Fri, 02 Oct 2026 09:33:44 +0000</pubDate>
				<category><![CDATA[Medicine]]></category>
		<category><![CDATA[ACE2 receptor]]></category>
		<category><![CDATA[ACE2 receptor binding]]></category>
		<category><![CDATA[Bat coronavirus immunity]]></category>
		<category><![CDATA[bat coronaviruses]]></category>
		<category><![CDATA[coronavirus host range]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[cross-immunity]]></category>
		<category><![CDATA[cross-reactive immune response]]></category>
		<category><![CDATA[immunity]]></category>
		<category><![CDATA[immunity from COVID-19 vaccination]]></category>
		<category><![CDATA[King's College London]]></category>
		<category><![CDATA[monoclonal antibodies]]></category>
		<category><![CDATA[Pandemic Preparedness]]></category>
		<category><![CDATA[pangolin and bat reservoirs]]></category>
		<category><![CDATA[Pirbright Institute]]></category>
		<category><![CDATA[sarbecovirus immune landscape]]></category>
		<category><![CDATA[SARS-CoV-2]]></category>
		<category><![CDATA[SARS-CoV-2 cross-protection]]></category>
		<category><![CDATA[SARS-related coronavirus research]]></category>
		<category><![CDATA[spillover risk]]></category>
		<category><![CDATA[viral spillover prevention]]></category>
		<category><![CDATA[zoonotic diseases]]></category>
		<category><![CDATA[zoonotic spillover risk]]></category>
		<guid isPermaLink="false">https://scienmag.com/?p=226923</guid>

					<description><![CDATA[A joint study by The Pirbright Institute and King’s College London finds that immunity from SARS-CoV-2 may protect against other bat coronaviruses with broad host ranges.]]></description>
										<content:encoded><![CDATA[<p>Scientists at The Pirbright Institute and King’s College London have revealed that immunity generated by SARS-CoV-2 infection or vaccination may offer significant protection against a range of other bat coronaviruses. This discovery, published in two companion articles in PLOS Biology, suggests that the widespread exposure of the human population to SARS-CoV-2 has inadvertently raised the biological barrier for related viruses attempting to spill over from animal reservoirs. The research provides a critical new perspective on pandemic preparedness, indicating that the immune landscape shaped by the current pandemic could serve as a partial shield against future zoonotic threats from the sarbecovirus sub-group.</p>
<p>The study focused on sarbecoviruses, the specific sub-group of coronaviruses that includes both SARS-CoV-1 and SARS-CoV-2. Researchers examined how these viruses interact with angiotensin-converting enzyme 2, or ACE2, the cellular receptor that many coronaviruses utilize to enter host cells. By investigating the ability of various bat coronaviruses to use ACE2 proteins from a broad spectrum of species, the team aimed to understand the host range of these viruses. This host range is a key determinant of spillover risk, as viruses capable of infecting a wide variety of animals are generally considered more likely to jump to humans.</p>
<p>The team analyzed fifteen representative bat coronavirus spike proteins using libraries of ACE2 receptors derived from thirty-four different species. These species included humans, livestock, rodents, and animals previously proposed as intermediate hosts in the transmission chain. The analysis revealed a distinct pattern in receptor usage among the different evolutionary groups of bat sarbecoviruses. Specifically, the researchers identified so-called generalist sarbecoviruses, which can utilize ACE2 receptors from many different species, and found that these were largely confined to the same evolutionary lineage as SARS-CoV-2.</p>
<p>Dr. Nazia Thakur, a postdoctoral scientist at Pirbright and the lead author of the study, explained that the bat coronaviruses currently considered most likely to spill over into humans are also the most likely to be recognized by existing COVID-19 immunity. She noted that while the risk of spillover can never be entirely eliminated, the global exposure to SARS-CoV-2 may have created a more robust immune defense against related viruses. This finding implies that the immune systems of many people are already primed to recognize and neutralize potential future pathogens that share structural similarities with the virus that caused the current pandemic.</p>
<p>The research also highlighted the dynamic nature of viral evolution during the pandemic. The team investigated how the host range of SARS-CoV-2 itself has changed over time. They found that variants, particularly those within the Omicron lineage, acquired specific mutations in the receptor binding domain. These mutations resulted in shifting patterns of ACE2 usage across different animal species, demonstrating that the relationship between viral evolution and host susceptibility is not static but continuously evolving in response to immune pressure and environmental factors.</p>
<p>To assess the practical implications for human health, the scientists examined blood samples from individuals who had recovered from COVID-19. The antibodies present in these samples were tested against a range of bat coronaviruses to measure their neutralizing capacity. The results showed that these antibodies successfully neutralized a variety of closely related bat coronaviruses. This cross-neutralization indicates that the immune response triggered by SARS-CoV-2 is not strictly specific to that single virus but extends to a broader family of related pathogens, providing a layer of protection against potential new infections.</p>
<p>Professor Katie Doores of King’s College London emphasized that the viruses showing the strongest antigenic similarity to SARS-CoV-2 were the most readily recognized and neutralized by the antibodies generated following infection. In contrast, more distantly related bat coronaviruses tended to be specialists, capable of using ACE2 receptors from only a limited range of hosts. However, the researchers also detected lower levels of neutralization against these more distant viruses, suggesting that there is some degree of broader protection even against pathogens that are not closely related to SARS-CoV-2.</p>
<p>Further experiments conducted at both institutions identified several monoclonal antibodies capable of recognizing a remarkably diverse range of sarbecoviruses. The second companion article in the study detailed where these monoclonal antibodies bind on the viral surface, highlighting conserved regions of the coronavirus spike protein. These conserved regions are less likely to mutate without compromising the virus&#8217;s ability to infect cells, making them ideal targets for the development of next-generation vaccines and therapeutics. This approach could lead to the creation of pan-sarbecovirus vaccines that offer protection against multiple strains simultaneously.</p>
<p>Dr. Dalan Bailey, head of the Viral Glycoproteins group at Pirbright, described the evidence of cross-neutralization of even some distantly related bat coronaviruses as an encouraging finding. He suggested that this capability points toward the feasibility of developing broadly protective vaccines or therapeutics that can cover a wide spectrum of sarbecoviruses. By targeting conserved epitopes, such interventions could provide a more durable and comprehensive defense against future zoonotic spillover events, reducing the likelihood of a new pandemic emerging from the bat reservoir.</p>
<p>The work underscores the importance of understanding virus host range, receptor usage, and immune recognition in an integrated manner rather than in isolation. By identifying the specific characteristics that distinguish higher-risk viruses from those less likely to spill over into humans, researchers hope to strengthen global pandemic preparedness efforts. This study provides a scientific basis for monitoring specific bat coronavirus lineages and developing targeted interventions that leverage existing immunity to protect against future viral threats, ultimately contributing to a more resilient global health system.</p>
<p><strong>Subject of Research:</strong> Cross-immunity between SARS-CoV-2 and bat sarbecoviruses via ACE2 receptor usage</p>
<p><strong>Article Title:</strong> COVID-19 immunity may help protect against other bat coronaviruses</p>
<p><strong>Article References:</strong> COVID-19 immunity may help protect against other bat coronaviruses. (n.d.). <a href="https://www.eurekalert.org/news-releases/1146070" rel="noopener noreferrer">Original publication</a></p>
<p><strong>Image Credits:</strong> AI Generated</p>
<p><strong>DOI:</strong> Not provided</p>
<p><strong>Keywords:</strong> SARS-CoV-2, bat coronaviruses, ACE2 receptor, cross-immunity, spillover risk, Pirbright Institute, King&#x27;s College London, pandemic preparedness, monoclonal antibodies, zoonotic diseases, COVID-19, immunity</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">226923</post-id>	</item>
		<item>
		<title>Mapping the Next Outbreak: How Satellites and GPS Are Reshaping Veterinary Medicine</title>
		<link>https://scienmag.com/mapping-the-next-outbreak-how-satellites-and-gps-are-reshaping-veterinary-medicine/</link>
		
		<dc:creator><![CDATA[William Thompson]]></dc:creator>
		<pubDate>Thu, 24 Sep 2026 19:27:35 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<category><![CDATA[disease surveillance]]></category>
		<category><![CDATA[environmental factors influencing disease outbreaks]]></category>
		<category><![CDATA[Ethiopia]]></category>
		<category><![CDATA[geospatial analysis of livestock health]]></category>
		<category><![CDATA[geospatial technologies]]></category>
		<category><![CDATA[geospatial technologies in veterinary medicine]]></category>
		<category><![CDATA[GIS]]></category>
		<category><![CDATA[GIS platforms for disease prediction]]></category>
		<category><![CDATA[global satellite systems for veterinary use]]></category>
		<category><![CDATA[GPS]]></category>
		<category><![CDATA[GPS collars for livestock monitoring]]></category>
		<category><![CDATA[livestock]]></category>
		<category><![CDATA[Machine learning]]></category>
		<category><![CDATA[mapping wildlife-livestock disease transmission]]></category>
		<category><![CDATA[One Health]]></category>
		<category><![CDATA[remote sensing]]></category>
		<category><![CDATA[remote sensing in veterinary epidemiology]]></category>
		<category><![CDATA[risk mapping]]></category>
		<category><![CDATA[satellite imagery for disease tracking]]></category>
		<category><![CDATA[satellite-based ecological data for disease spread]]></category>
		<category><![CDATA[spatial data integration in veterinary research]]></category>
		<category><![CDATA[technological barriers in veterinary geospatial tools]]></category>
		<category><![CDATA[Veterinary Epidemiology]]></category>
		<category><![CDATA[zoonotic diseases]]></category>
		<guid isPermaLink="false">https://scienmag.com/?p=212470</guid>

					<description><![CDATA[A new review maps how GIS, GPS, and remote sensing are transforming veterinary disease surveillance while exposing deep gaps in infrastructure, data quality, and ethics.]]></description>
										<content:encoded><![CDATA[<p>A quiet revolution is unfolding in the way veterinarians track disease across the planet. Satellite imagery, GPS collars, and geographic information systems—tools once confined to cartographers and urban planners—are now central to predicting where foot-and-mouth disease will strike next, where ticks will flourish, and how a virus might leap from wildlife to livestock. A new narrative review published in Discover Animals by Assaye Wollelie Fentie and Daniel Haile Asefa of Woldia University in Ethiopia synthesizes the state of geospatial technologies in veterinary medicine, cataloguing both their remarkable successes and the stubborn barriers that keep them out of reach for much of the world.</p>
<p>The review focuses on three interlocking technologies. Geographic Information Systems, or GIS, are computerized platforms for capturing, storing, integrating, analyzing, and visualizing spatially referenced data, allowing researchers to overlay disease reports with environmental variables and livestock densities. The Global Positioning System and its international counterparts under the Global Navigation Satellite Systems umbrella supply precise coordinates for tracking herds, geotagging outbreak cases, and monitoring pastoral movements. Remote sensing completes the triad, drawing on satellite and aerial platforms to measure the ecological drivers of disease—vegetation cover, rainfall, temperature, humidity, and landscape structure—that shape where vectors and pathogens thrive.</p>
<p>The evidence base assembled by the authors is striking. GIS-based mapping of Rift Valley fever outbreaks in East Africa has enabled rapid identification of epidemiological hotspots and guided vaccination campaigns to the areas of greatest risk. In southern Africa, remotely sensed vegetation indices have successfully predicted tick distribution patterns, sharpening targeted acaricide interventions and reducing livestock morbidity. In Ethiopia itself, GIS has been used to map the distribution of Peste des Petits Ruminants along pastoral mobility corridors, letting veterinary authorities pinpoint high-risk zones and prioritize vaccination. Risk mapping of lumpy skin disease virus in the Oromia region revealed strong correlations between outbreak intensity and humid lowland agro-ecologies, underscoring how environmental drivers shape disease distribution.</p>
<p>What makes these tools particularly powerful is their synergy with molecular diagnostics. While genomic assays identify pathogens with precision, GIS and remote sensing contextualize those findings—mapping pathogen distribution, tracing transmission pathways, and linking them to ecological drivers. The review cites the pairing of genomic confirmation of PPR outbreaks in Ethiopia with GIS-based mapping of pastoral mobility routes, a combination that produces both a precise diagnosis and a spatially informed intervention strategy. This fusion of laboratory science and landscape analysis represents a comprehensive framework for modern veterinary epidemiology.</p>
<p>The analytical machinery behind these maps has grown considerably more sophisticated. Spatial autocorrelation statistics such as Moran&#8217;s I and Geary&#8217;s C test whether disease cases cluster, disperse, or scatter randomly. Scan statistics identify statistically significant outbreak clusters, supporting early detection of epidemic hotspots in diseases like foot-and-mouth and avian influenza. Kernel density estimation and Getis-Ord Gi hotspot analysis visualize areas of unusually high or low risk, and have been applied to rabies and tick-borne disease foci. Geographically weighted regression captures risk-factor relationships that vary across space, while Bayesian frameworks such as BYM2 provide robust disease mapping for endemic infections like bovine tuberculosis, accounting for uncertainty and spatial dependence even in sparse datasets. Livestock movement network analysis identifies high-risk corridors and nodes for disease transmission, critical for controlling transboundary diseases.</p>
<p>Beyond livestock, the technologies are reshaping wildlife and zoonotic disease monitoring—a domain of growing urgency given that zoonotic diseases represent nearly half of all known human pathogens. GPS collars on wildlife have revealed movement patterns that overlap with livestock grazing areas, raising risks of tick-borne diseases such as East Coast fever and Lyme disease and helping anticipate spillover at the wildlife-livestock-human interface. Unmanned aerial vehicles have been deployed to estimate free-roaming dog populations for rabies surveillance and to map ecological risk zones for fascioliasis. These applications align with international frameworks including the World Organisation for Animal Health standards, the FAO&#8217;s EMPRES-i system, and the WHO-FAO-WOAH Global Early Warning System, all of which emphasize geospatial integration within the One Health approach.</p>
<p>Food safety and international trade represent another frontier. GIS has been used to trace contamination sources in meat and dairy supply chains, while GPS tracking of transport routes improves compliance with international standards for animal products—capabilities particularly relevant for trade-sensitive diseases such as bovine tuberculosis and brucellosis. Geospatially referenced datasets like the FAO&#8217;s Gridded Livestock of the World strengthen population monitoring, and GIS-based mapping of livestock transport routes and abattoir locations in Ethiopia has been used to trace potential contamination pathways and support export certification requirements, operationalizing Codex Alimentarius traceability principles in practice.</p>
<p>Yet the review is candid about the obstacles. In Ethiopia, recent surveys indicate that fewer than 20 percent of veterinary institutions actively use GIS platforms for routine surveillance, and remote sensing remains limited to pilot projects within national veterinary services. Technical and infrastructure barriers loom large: grassroots organizations and veterinary services often lack the time, skills, and financial resources to deploy GIS effectively, and persistent cloud cover over highland and humid regions degrades satellite imagery, demanding multi-sensor integration and radar-based alternatives. Data quality problems—incomplete datasets, coarse spatial resolution, limited nighttime data, and the unstructured nature of big data—continue to undermine reliability. Adoption, the authors stress, is not merely a technical exercise but a long-term institutional commitment requiring skilled personnel, supportive frameworks, and sustained investment.</p>
<p>The statistical pitfalls are equally consequential. Ecological fallacy can lead researchers to wrongly infer that associations observed at the district level apply to individual herds. The modifiable areal unit problem means analytical results can shift depending on the spatial boundaries chosen. Ignoring spatial autocorrelation inflates statistical significance, while uneven surveillance coverage and under-reporting in resource-limited settings distort risk maps, making well-monitored areas appear artificially high-risk. Temporal mismatches between satellite-derived environmental data and disease occurrence records further weaken causal inference. Ground-truthing and careful validation against local ecological conditions remain essential, since remotely sensed variables are not always reliable proxies for pathogen ecology—satellite temperature or vegetation indices may miss the microclimatic conditions critical for vector survival.</p>
<p>Ethical and policy questions add another layer of complexity. Publishing high-resolution disease maps can inadvertently identify individual farms or owners, exposing them to economic losses, trade restrictions, or social stigma, while disclosing wildlife locations may increase poaching risks. Veterinary geospatial datasets typically involve multiple stakeholders—farmers, veterinary services, research institutions, and governments—making clear policies on data ownership, access, and confidentiality essential. The authors argue for responsible data governance in which outputs are anonymized, aggregated, and contextualized, balancing the benefits of open data for rapid outbreak response against the risks of exposing sensitive information.</p>
<p>The path forward, the review suggests, runs through open-source platforms and international collaboration. Tools such as QGIS and Google Earth Engine offer cost-effective entry points—QGIS has been applied to mapping African swine fever risk zones and rabies surveillance in resource-constrained settings, while Google Earth Engine has enabled large-scale integration of Sentinel-1 and Sentinel-2 imagery for pasture productivity monitoring and disease risk prediction. Training initiatives like the FAO&#8217;s ISAVET program have already taught veterinarians GIS-based surveillance across sub-Saharan Africa, and the WOAH Twinning Programmes connect institutions in Africa and Asia with advanced reference centers. Lessons from COVID-19 dashboards demonstrate how real-time GIS can be adapted to veterinary threats including foot-and-mouth disease, PPR, and avian influenza.</p>
<p>Looking ahead, the authors see artificial intelligence and machine learning transforming the field: AI-driven outbreak forecasting, convolutional neural networks that classify livestock behaviors, satellite-image classification, and vector-habitat modeling all promise to anticipate epidemics before they escalate. Internet-of-Things-enabled animal tracking and mobile GIS will push data collection directly into pastoral and rural areas, while drones extend surveillance into inaccessible terrain. But technology alone will not suffice. The review&#8217;s recommendations—national geospatial data repositories with clear policy backing, mapping of pastoral livestock mobility, integration of drought monitoring into veterinary early warning systems, and geotagging of clinics and laboratories to identify underserved areas—point to a future where geospatial thinking is embedded in the institutional fabric of veterinary medicine. Closing the gap between what satellites can see and what veterinary services can act upon, the authors conclude, will be essential for disease control, public health, and the resilience of the livestock systems that feed a growing world.</p>
<p><strong>Subject of Research:</strong> Applications and challenges of geospatial technologies in veterinary disease surveillance</p>
<p><strong>Article Title:</strong> Applications and challenges of geospatial technologies in veterinary medicine</p>
<p><strong>Article References:</strong> Fentie, A. W., &amp; Asefa, D. H. (2026). Applications and challenges of geospatial technologies in veterinary medicine. <em>Discover Animals, 3</em>(1), Article 95. <a href="https://doi.org/10.1007/s44338-026-00259-y" rel="noopener noreferrer">https://doi.org/10.1007/s44338-026-00259-y</a></p>
<p><strong>Image Credits:</strong> AI Generated</p>
<p><strong>DOI:</strong> <a href="https://doi.org/10.1007/s44338-026-00259-y" rel="noopener noreferrer">10.1007/s44338-026-00259-y</a></p>
<p><strong>Keywords:</strong> geospatial technologies, GIS, remote sensing, GPS, veterinary epidemiology, disease surveillance, risk mapping, One Health, zoonotic diseases, livestock, Ethiopia, machine learning</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">212470</post-id>	</item>
	</channel>
</rss>
